Status:
COMPLETED
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
Lead Sponsor:
Dokkyo Medical University
Conditions:
Type 2 Diabetes
Hypertension
Eligibility:
All Genders
20-70 years
Brief Summary
We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.
Detailed Description
Primary composite endpoints: Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine) Secondary endpoints: urinary ...
Eligibility Criteria
Inclusion
- type 2 diabetes HbA1c: more than 7% and less than 9%
Exclusion
- insulin treatment
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
End Date :
July 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00419484
Start Date
March 1 2004
End Date
July 1 2008
Last Update
January 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dokkyo Medical University, Koshigaya Hospital
Koshigaya, Saitama, Japan, 343-8555